...
首页> 外文期刊>American Journal of Physiology >Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy
【24h】

Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy

机译:2型糖尿病肾病患者肾脏中的加速衰老

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We examined the hypothesis that senescence represents a proximate mechanism by which the kidney is damaged in type 2 diabetic nephropathy (DN). As a first step, we studied whether the senescence-associated betaP-galactosidase (SA-beta-Gal) and the cell cycle inhibitor pl6~(INK4A) are induced in renal biopsies from patients with type 2 DN. SA-|5-Gal staining was approximately threefold higher (P < 0.05) than in controls in the tubular compartment of diabetic kidneys and correlated directly with body mass index and blood glucose. p16~(INK4A) expression was significantly increased in tubules (P < 0.005) and in podocytes (P = 0.04). Nuclear pl6~(INK4A) in glomeruli was associated with proteinuria (P < 0.002), while tubular pl6~(INK4A) was directly associated with body mass index, LDL cholesterol, and HbAlc (P < 0.001-0.05). In a parallel set of experiments, proximal tubule cells passaged under high glucose presented a limited life span and an approximately twofold increase in SA-beta-Gal and pl6~(INK4A) protein. Mean telomere lengths decreased ~20% as an effect of replicative senescence. In addition, mean telomere decreased further by -30% in cells cultivated under high glucose. Our results show that the kidney with type 2 diabetic nephropathy displays an accelerated senescent phenotype in defined renal cell types, mainly tubule cells and, to a lesser extent, podocytes. A similar senescent pattern was observed when proximal tubule cell cultures where incubated under high-glucose media. These changes are associated with shortening tubular telomere length in vitro. These findings indicate that diabetes may boost common pathways involving kidney cell senescence, thus reinforcing the role of the metabolic syndrome on biological aging of tissues.
机译:我们检查了这一假设,即衰老是2型糖尿病肾病(DN)中肾脏受损的近端机制。第一步,我们研究了在2型DN患者的肾脏活检中是否诱导了衰老相关的betaP-半乳糖苷酶(SA-beta-Gal)和细胞周期抑制剂pl6〜(INK4A)。 SA- | 5-Gal染色比糖尿病肾小管腔中的对照高大约三倍(P <0.05),并且与体重指数和血糖直接相关。在肾小管(P <0.005)和足细胞(P = 0.04)中,p16〜(INK4A)表达显着增加。肾小球中的核pl6〜(INK4A)与蛋白尿有关(P <0.002),而肾小管pl6〜(INK4A)与体重指数,LDL胆固醇和HbAlc直接相关(P <0.001-0.05)。在一组平行的实验中,在高葡萄糖下传代的近端肾小管细胞的寿命有限,SA-β-Gal和p16〜(INK4A)蛋白大约增加两倍。由于复制衰老,平均端粒长度减少了约20%。此外,在高葡萄糖条件下培养的细胞中,平均端粒进一步降低了-30%。我们的研究结果表明,患有2型糖尿病肾病的肾脏在定义的肾细胞类型(主要是肾小管细胞,以及程度较小的足细胞)中显示出加速的衰老表型。当近端肾小管细胞培养物在高葡萄糖培养基下孵育时,观察到相似的衰老模式。这些变化与体外肾小管端粒长度的缩短有关。这些发现表明,糖尿病可以促进涉及肾细胞衰老的常见途径,从而增强了代谢综合征对组织生物衰老的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号